Efficacy testing in mouse models of proteinuric kidney disease (adriamycin-induced nephropathy and Alport syndrome) revealed that Cpds A and G normalize proteinuria, and significantly reduce renal fibrosis and renal functional decline. The gene discussed is HOMER2; the disease is Alport syndrome.